ACADIA Pharmaceuticals Inc at RBC Global Healthcare Conference Transcript
Thank you, everybody, for joining us again today. My name is Greg Renza, one of the RBC Capital Market's technology equity research analyst. And we are joined now by ACADIA Pharmaceuticals. Very excited to have the team here today. And with us is Steve Davis; Chief Executive Officer; Dr. Serge Stankovic, President; and Elena Ridloff, Executive Vice President and Chief Financial Officer.
Team, thank you very much, and we look forward to talking about the ACADIA story.
Thank you, Greg.
Steve, maybe the best way for us -- great. Maybe the best way for us to start is just to allow you the opportunity to give a brief introduction of the company, what your latest thinking is on the key 3 strategic pillars of ACADIA and how that has essentially evolved over time?
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
